STAVANGER, Norway, Dec. 18, 2015 (GLOBE NEWSWIRE) -- The shares of a primary insider's spouse was missing in the reporting of share trading on behalf of Statoil ASA (OSE:STL, NYSE:STO) on 15 December 2015.
This is a correction of the announcement of 15.12.2015 09:15 CEST. The correction regards a missing number in the share trading reporting of a primary insider's spouse.
As a participant in Statoil's share saving programme, primary insider Margareth Øvrum in Statoil ASA has on 15 December 2015 been allocated shares at an average price of NOK 135 per share:
| Name | Allocated shares | New shareholding |
| Øvrum, Margareth | 1039 | 42621 |
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
HUG#1974789
CONTACT: Hilde Merete Nafstad, SVP Investor Relations, mbl +47 95783911
Morten Sven Johannessen, VP Investor Relations USA, mbl +1 203 570 2524


Apple Turns 50: From Garage Startup to AI Crossroads
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic 



